CDC Director Nominee Deadline Looms as Vacancy Exceeds 210 Days

The White House faces a rapidly approaching deadline to nominate a permanent director for the Centers for Disease Control and Prevention (CDC), yet remains publicly silent on its plans. The federally mandated limit of 210 days for temporary leadership at an executive branch agency is drawing near, raising questions about potential disruptions to public health leadership.

The current situation stems from a series of temporary appointments following the firing of Susan Monarez, PhD, as CDC director on August 27, 2025. As reported by Healio, Jim O’Neill initially served as acting director until February 13, 2026, when NIH Director Jay Bhattacharya, MD, PhD, was selected to temporarily lead the agency.

The Vacancies Reform Act dictates that an executive branch position cannot be temporarily filled for more than 210 days from the date the vacancy occurs. According to Lawrence O. Gostin, JD, professor and founding director of the O’Neill Institute for National and Global Health Law at Georgetown University, this clock continues running regardless of how many individuals serve in an acting capacity. “This clock pauses while a nominee is pending in the Senate, and a novel 210-day period begins if a nominee is rejected, withdrawn or returned,” Gostin explained.

With O’Neill and Bhattacharya’s combined tenure nearing the 210-day mark – calculated to be March 25, 2026 – the White House has approximately one week to put forward a nominee. Multiple requests to the White House for comment on its plans have gone unanswered.

Implications of Exceeding the Deadline

Should the 210-day limit be surpassed without a nominee, the Comptroller General is required to report the situation to relevant congressional committees. This could prompt increased scrutiny from Congress and pressure on the administration to nominate a permanent director. The Vacancies Reform Act allows for potential legal challenges, with courts potentially nullifying actions taken by the acting director if deemed noncompliant with the law. A summary from The Library of Congress details these potential legal ramifications. More information on the Vacancies Act can be found here.

A Period of Interim Leadership

The past 14 months have seen a reliance on non-experts to make critical decisions at the CDC, including approvals related to recommendations from the Advisory Committee on Immunization Practices (ACIP). Healio reported in February that former CDC leaders expressed concerns that the lack of permanent leadership jeopardizes national health and safety. This extended period of interim leadership raises questions about the continuity and stability of public health initiatives.

Shifting Confirmation Landscape

The process for confirming a CDC director has become more complex in recent years. Previously, a presidential nominee could be appointed without further action. Now, Senate confirmation is required, adding a layer of political consideration. The Senate Committee on Health, Education, Labor and Pensions, currently chaired by Senator Bill Cassidy (R-LA), plays a crucial role in vetting nominees. Senator Cassidy has publicly criticized the performance of Robert F. Kennedy Jr., the current HHS secretary, particularly regarding his handling of the CDC and vaccine policy, having cast the deciding vote to confirm him. This history suggests the White House may face a more challenging confirmation process this year compared to the confirmation of Monarez last year.

The Role of the Senate Committee

The Senate Committee on Health, Education, Labor and Pensions holds significant sway over the confirmation process. Its chairman, Senator Cassidy, has demonstrated a willingness to scrutinize the administration’s choices, particularly concerning public health matters. This dynamic adds another layer of uncertainty to the nomination process and underscores the political challenges the White House faces in securing a permanent CDC director.

What Comes Next: Procedural Steps and Potential Oversight

The coming weeks will be critical. The White House must decide whether to nominate a candidate before March 25th. If a nominee is put forward, they will face scrutiny from the Senate Committee on Health, Education, Labor and Pensions, followed by a full Senate vote. If the 210-day deadline passes without a nominee, expect increased congressional oversight and potential legal challenges. The CDC will continue to operate under the temporary leadership of Dr. Bhattacharya, but the long-term implications of prolonged interim leadership remain a concern for public health officials.

Lawrence O. Gostin, JD, can be reached at [email protected].